BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18234430)

  • 21. Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma.
    Tomita N; Kodaira T; Tachibana H; Nakamura T; Mizoguchi N; Takada A
    Radiother Oncol; 2009 Feb; 90(2):231-5. PubMed ID: 19135751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orbital lymphoma: is it necessary to treat the entire orbit?
    Pfeffer MR; Rabin T; Tsvang L; Goffman J; Rosen N; Symon Z
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):527-30. PubMed ID: 15380588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
    Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ
    J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
    Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
    Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence patterns of mucose-associated lymphoid tissue lymphoma after definitive radiation treatment: A single center experience.
    Joo JH; Lee SW; Huh J; Suh C; Yoon DH; Ahn SD; Choi EK; Kim JH
    Hematology; 2016 Oct; 21(9):542-8. PubMed ID: 27168138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary dural lymphoma mimicking a subdural hematoma.
    Gocmen S; Gamsizkan M; Onguru O; Sefali M; Erdogan E
    J Clin Neurosci; 2010 Mar; 17(3):380-2. PubMed ID: 20079653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity.
    Goda JS; Le LW; Lapperriere NJ; Millar BA; Payne D; Gospodarowicz MK; Wells W; Hodgson DC; Sun A; Simpson R; Tsang RW
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e659-66. PubMed ID: 21640514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracranial non-Hodgkin's MALT lymphoma mimicking a large convexity meningioma.
    Pavlou G; Pal D; Bucur S; Chakrabarty A; van Hille PT
    Acta Neurochir (Wien); 2006 Jul; 148(7):791-3; discussion 793. PubMed ID: 16570114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
    Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
    J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric mucosa-associated lymphoid tissue lymphoma detected by clonotypic polymerase chain reaction despite continuous pathologic remission induced by involved-field radiotherapy.
    Noy A; Yahalom J; Zaretsky L; Brett I; Zelenetz AD
    J Clin Oncol; 2005 Jun; 23(16):3768-72. PubMed ID: 15923573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary diffuse large B-cell central nervous system lymphoma presenting as an acute space-occupying subdural mass.
    Sacho RH; Kogels M; du Plessis D; Jowitt S; Josan VA
    J Neurosurg; 2010 Aug; 113(2):384-7. PubMed ID: 20225921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary malignant B-cell-type dural lymphoma: Case report.
    Yamada SM; Ikawa N; Toyonaga S; Nakabayashi H; Chang Park K; Shimizu K
    Surg Neurol; 2006 Nov; 66(5):539-43; discussion 543. PubMed ID: 17084207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary intracranial dural lymphoma of mucosa-associated lymphoid tissue (MALT) type: report of one case and review of the literature.
    George AC; Ozsahin M; Janzer R; Agassis S; Meuli R; Baur AS; Frossard V; Leyvraz S; Ketterer N
    Bull Cancer; 2005 Jul; 92(7):E51-6. PubMed ID: 16122999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk.
    Koh ES; Tran TH; Heydarian M; Sachs RK; Tsang RW; Brenner DJ; Pintilie M; Xu T; Chung J; Paul N; Hodgson DC
    Radiat Oncol; 2007 Mar; 2():13. PubMed ID: 17362522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosa-associated lymphoma tissue of the dura presenting as meningioma.
    Shaia J; Kerr PB; Saini A; Roberti F; Kapil J; Jones R; Aragon-Ching JB
    South Med J; 2010 Sep; 103(9):950-2. PubMed ID: 20689487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma.
    Nam H; Ahn YC; Kim YD; Ko Y; Kim WS
    Radiother Oncol; 2009 Feb; 90(2):236-41. PubMed ID: 18950885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracranial mucosa-associated lymphoid tissue (MALT) lymphoma.
    Ferguson SD; Musleh W; Gurbuxani S; Shafizadeh SF; Lesniak MS
    J Clin Neurosci; 2010 May; 17(5):666-9. PubMed ID: 20202849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracranial meningeal hemangiopericytoma: 10 years experience of a tertiary care Institute.
    Kumar N; Kumar R; Kapoor R; Ghoshal S; Kumar P; Salunke PS; Radotra BD; Sharma SC
    Acta Neurochir (Wien); 2012 Sep; 154(9):1647-51. PubMed ID: 22790838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell Lymphoma.
    Lee GI; Oh D; Kim WS; Kim SJ; Ko YH; Woo KI; Kim YD; Ahn YC
    Cancer Res Treat; 2018 Apr; 50(2):575-581. PubMed ID: 28618774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.